Volume : 11, Issue : 01, January – 2024
Title:
RESEALED ERYTHROCYTES: A NOVEL APPROACH TO TREAT CHRONIC DISEASES
Authors :
Salva. Kavya, Dr. K. Umasankar, Musali. Charitha, Naraganti. Sai Vani, Anam. Hananya
Abstract :
In this area of pharmaceutical innovation, there are more than 30 different drug delivery systems. As people become more interested in consuming safe medications that can be delivered to the intended target spot with few adverse effects, the current environment is concentrating more on targeted drug delivery systems. In actuality, the bio-distribution of medications throughout the body is essentially the fundamental issue with systemic drug delivery. An innovative drug administration method using resealed erythrocytes is now required to solve this issue and increase patient compliance and efficiency. Blood is drawn from the target organism, and erythrocytes and plasma are separated to create carrier erythrocytes. The cells are broken up in a few different ways, the erythrocytes are then hooked up to the drug, they are then resealed, and the resulting carriers are referred to as “resealed erythrocytes”. The negative effects of numerous medications, including aspirin, steroids, and cancer treatments, are reduced by resealing erythrocytes. Because they can circulate throughout the entire body and are biocompatible, sealed erythrocytes are becoming more and more important. They also exhibit zero order release kinetics, complete biodegradability, lack of hazardous product, predictable life span, and lowering drug side effects. And these play a big role in treating chronic illnesses like drug addiction, cancer, diabetes mellitus, rheumatoid arthritis, and HIV infection.
Keywords: Resealed Erythrocytes, Erythrocytes, Erythrosomes, Red Blood Cells, Drug Carriers.
Cite This Article:
Please cite this article in press Salva. Kavya et al., Resealed Erythrocytes: A Novel Approach To Treat Chronic Diseases, Indo Am. J. P. Sci, 2024; 11 (01).
Number of Downloads : 10
References:
1.Lewis D. A and Alpar H. O, Therapeutic Possibilities of Drugs Encapsulated in Erythrocytes, Int. J. Pharm, 22, 1984, 137– 146.
2. Jaitely V, Resealed Erythrocytes: Drug Carrier Potentials and Biomedical Applications, Ind. Drugs, 33, 1996, 589–594.
3. Summers M. P, Recent Advances in Drug Delivery, Pharm. J, 230, 1983, 643–645.
4. Torotra G. J and Grabowski S. R, The Cardiovascular System: The Blood, Principles of Anatomy and Physiology, Harper Collins College Publishers, New York, 7thed, 1993, 566–590.
5. Vyas S. P and Khar R. K, Resealed Erythrocytes in Targeted and Controlled Drug Delivery, Novel Carrier Systems, CBS Publishers and Distributors, India, 2002, 87–416.
6. Deloach J. R, Harris R. L and Ihler G. M, An Erythrocyte Encapsulator Dialyzer Used in Preparing Large Quantities of Erythrocyte Ghosts and Encapsulation of a Pesticide in Erythrocyte Ghosts, Anal. Biochem, 102, 1980, 220–227.
7. Ihler G. M, Erythrocyte Carriers, Pharmacology & Therapeutics, 20, 1983, 151–169
8. Summer M. P, Recent Advances in Drug Delivery, Pharm. J, 230, 1983, 643–645.
9. Eichler H. C, In Vitro Drug Release from Human Carrier Erythrocyte AS Carrier System, Advance in Bioscience, 67, 1987, 11-15.
10. DeLoach J. R, Methods in Enzymology, Academic Press, New York, 1987, 235.
11. Carmen Gutierrez Millan, Maria Luisa Sayalero Marinero, Aranzazu Zarzuelo Castaneda and Jose M. Lanao, Drug, Enzyme and Peptide delivery using erythrocytes as carriers, Journal of Controlled Release, 95(1), 2004, 27-49.
12.MehrdadHamidi, Adbolhossein Zarrina, Mahshid Foroozesha and Soliman Mohammadi-Samania, Applications of carrier erythrocytes in delivery of biopharmaceuticals, Journal of Controlled Release, 118(2), 2007, 145-160.
13. Ihler G. M, Erythrocyte Carriers, Pharmacol. Ther, 20, 1989, 151– 169
14. Torotra G. J and Grabowski S. R, The Cardiovascular System: The Blood, in Principles of Anatomy and Physiology, Harper Collins College Publishers, New York,7thed, 1993, 566–590.
15. Shashank shah, Novel Drug Delivery Carrier: Resealed Erythrocytes, International Journal of Pharma and Bio Sciences, 2(1), 2011, 394‐406.
16. Tyrrell D. A, Ryman B. E, Encapsulation of PEG Urease/PEG-Ala DH within Sheep Erythrocytes and Determination of the System’s Activity in Lowering Blood Levels of Urea in Animal Models, biochemistry soc. trans, 4, 1976, 677.
17. DeLoach J. R,Ihler G. M, Carrier Erythrocyte, Biochem. Biophys. Acta, 1979, 496-136.
18. Gothoskar A. V, Resealed Erythrocytes: A Review, Pharmaceutical Technology, March 2004, 140-141.
19. Panchal R, Resealed Erythrocytes: A Novel Drug Delivery System, Journal of Pharmaceutics and Cosmetology, September 2006, 21- 22.
20. Roman Hudeca, Boris Lakatos, Reconstitution of the basal calcium transport in resealed human red blood cell ghosts, Biochemical and Biophysical Research Communications, 325, 2004, 1172.
21. Telen MJ and Kaufman ER, The mature erythrocytes, Clinical Hematology, 11thed, Publishers Lippincott Williams & Wilkins, Philadelphia, 2004, 217-247.
22. Bull BS, Morphology of Erythron, Williams’ Hematology, 6thed, Publishers, McGraw-Hill New York, 2001, 271-293.
23. Gardos G, Akkumulation de kaliumonendurchmen schiche Blutkorperchen Acta, Physiol AcadSci Hung, 6, 1953, 191-196.
24. Marsden NVB and Ostling SG, Accumulation of dextran in human red blood cells after hemolysis, Nature, 184, 1959, 723-724.
25. Iher GM, Glew RM, Schnure FW, Enzyme loading of erythrocytes, ProcNatlAcadSci USA, 70, 1973, 2663-2666.
26. Zimmermann U, Jahresbericht der kernforschungsanlageJulich GmbH, Nuclear Research Center Julich, 1973, 55-58.